本文選題：數(shù)據(jù)包絡分析 + 醫(yī)藥制造業(yè)研發(fā)效率�。� 參考：《理論月刊》2016年03期

【摘要】：醫(yī)藥制造業(yè)是關系國計民生的重要產業(yè),一個地區(qū)的醫(yī)藥制造業(yè)的研發(fā)效率決定了這個地區(qū)該行業(yè)的發(fā)展后勁。為此,本文基于省際數(shù)據(jù)構建中國醫(yī)藥制造業(yè)研發(fā)效率評價模型,運用DEA分析方法,采用投入導向型的BC2模型分析我國31個省份醫(yī)藥制造業(yè)研發(fā)效率。研究發(fā)現(xiàn)我國目前3個省份醫(yī)藥制造業(yè)研發(fā)效率有效,28個省份醫(yī)藥制造業(yè)存在研發(fā)資源投入冗余或者研發(fā)產出不足。同時我國19個省份醫(yī)藥制造業(yè)存在著低技術效率,高規(guī)模效率的研發(fā)狀況,需要進行合理的資源配置,實現(xiàn)研發(fā)效率的相對有效,這一發(fā)現(xiàn)為相關工業(yè)管理部門進行醫(yī)藥制造業(yè)研發(fā)資源有效地配置提供經驗證據(jù)。
[Abstract]:Pharmaceutical manufacturing industry is an important industry related to the national economy and the people's livelihood. The R & D efficiency of a region's pharmaceutical manufacturing industry determines the development of this area. Therefore, based on the provincial data, this paper constructs the evaluation model of the R & D efficiency of Chinese pharmaceutical manufacturing industry, and uses the DEA analysis method and the investment-oriented BC2 model to analyze the R & D efficiency of the pharmaceutical manufacturing industry in 31 provinces of China. It is found that the R & D efficiency of pharmaceutical manufacturing industry is effective in 3 provinces of China, and that R & D resources are redundant or R & D output is insufficient in 28 provinces. At the same time, the pharmaceutical manufacturing industry in 19 provinces of China has low technical efficiency and high scale efficiency of R & D, so it is necessary to allocate reasonable resources to realize the relative effectiveness of R & D efficiency. The findings provide empirical evidence for the efficient allocation of R & D resources for pharmaceutical manufacturing by relevant industrial management departments.
【作者單位】： 南京曉莊學院商學院;河海大學商學院;
【基金】：國家社科基金項目(11BJY023) 江蘇省軟科學課題(SBR2014000246)
【分類號】：F426.72
，

本文編號：1986511